Benzinga - Sun, 09 May 2021 10:20:32 -0400
Benzinga - Fri, 07 May 2021 07:40:07 -0400
Benzinga - Thu, 06 May 2021 07:49:39 -0400
Benzinga - Wed, 05 May 2021 07:43:28 -0400
Benzinga - Tue, 04 May 2021 10:12:44 -0400
Benzinga - Thu, 22 Apr 2021 08:08:59 -0400
Benzinga - Wed, 21 Apr 2021 10:35:05 -0400
Benzinga - Tue, 20 Apr 2021 12:08:11 -0400
Benzinga - Tue, 20 Apr 2021 11:59:12 -0400
Benzinga - Tue, 20 Apr 2021 10:44:54 -0400
Benzinga - Tue, 20 Apr 2021 10:38:05 -0400
Benzinga - Tue, 20 Apr 2021 10:05:12 -0400
Benzinga - Tue, 20 Apr 2021 08:04:11 -0400
Benzinga - Tue, 20 Apr 2021 04:56:52 -0400
Benzinga - Mon, 19 Apr 2021 12:06:03 -0400
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q4 2021Est.ActualSurprise
EPS0.670

(EXPECTED) 2021-05-13

REV222.980M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HAEHaemonetics-0.67%3.1B

Haemonetics Company Questions & Answers

Q

How do I buy Haemonetics (HAE) stock?

A

You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Haemonetics's (HAE) main competitors?

A

Other companies in Haemonetics’s space includes: SI-BONE (NASDAQ:SIBN), BioLife Solutions (NASDAQ:BLFS) and Align Tech (NASDAQ:ALGN).

Q

What is the target price for Haemonetics?

A

The latest price target for Haemonetics (NYSE: HAE) was reported by Morgan Stanley on 2021-04-20. The analyst firm set a price target for 83.00 expecting HAE to rise to within 12 months (a possible 36.00% upside). 18 analyst firms have reported ratings in the last year.

Q

How much is Haemonetics (HAE) stock ?

A

The stock price for Haemonetics (NYSE: HAE) is $61.03 last updated Fri May 07 2021 19:59:54 GMT+0000 (Coordinated Universal Time).

Q

When is the next Haemonetics (HAE) dividend?

A

There are no upcoming dividends for Haemonetics.

Q

When is Haemonetics (NYSE:HAE) reporting earnings?

A
Haemonetics’s Q1 earnings are confirmed from now on August 3, 2021.
Q

When is the upcoming split for HAE?

A

There is no upcoming split for Haemonetics.